Landi D. Continuation of natalizumab versus interruption is associated with lower risk of relapses during pregnancy and postpartum in women with MS. Abstract 338. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Gen-omgevingsinteracties bij ALS: rol van roken, alcohol, BMI en C9orf72-status
mei 2021 | Neuro-musculair